Docosahexaenoic Acid and Cognition throughout the Lifespan

Bryan, 2004, Nutrients for cognitive development in school-aged children, Nutr. Rev., 62, 295, 10.1111/j.1753-4887.2004.tb00055.x

Brenna, 2007, The influence of dietary docosahexaenoic acid and arachidonic acid on central nervous system polyunsaturated fatty acid composition, Prostaglandins Leukot. Essent. Fat. Acids, 77, 247, 10.1016/j.plefa.2007.10.016

Rapoport, 1999, In vivo fatty acid incorporation into brain phospholipids in relation to signal transduction and membrane remodeling, Neurochem. Res., 24, 1403, 10.1023/A:1022584707352

Garcia, 1998, Effect of docosahexaenoic acid on the synthesis of phosphatidylserine in rat brain in microsomes and C6 glioma cells, J. Neurochem., 70, 24, 10.1046/j.1471-4159.1998.70010024.x

Suzuki, 1997, Rapid incorporation of docosahexaenoic acid from dietary sources into brain microsomal, synaptosomal and mitochondrial membranes in adult mice, Int. J. Vitam. Nutr. Res., 67, 272

Uauy, 2006, Nutrition in brain development and aging: Role of essential fatty acids, Nutr. Rev., 64, S24, 10.1301/nr.2006.may.S24-S33

Haubner, 2007, The effects of maternal dietary docosahexaenoic acid intake on rat pup myelin and the auditory startle response, Dev. Neurosci., 29, 460, 10.1159/000107047

Orr, 2008, The emerging role of docosahexaenoic acid in neuroinflammation, Curr. Opin. Investig. Drugs, 9, 735

Guesnet, 1999, n-3 and n-6 fatty acid enrichment by dietary fish oil and phospholipid sources in brain cortical areas and nonneural tissues of formula-fed piglets, Lipids, 34, 5, 10.1007/s11745-999-331-6

Anderson, 1998, Attentional skills following traumatic brain injury in childhood: A componential analysis, Brain Inj., 12, 937, 10.1080/026990598121990

Barkley, 2001, The executive functions and self-regulation: An evolutionary neuropsychological perspective, Neuropsychol. Rev., 11, 1, 10.1023/A:1009085417776

Kuratko, 2013, The relationship of docosahexaenoic acid (DHA) with learning and behavior in healthy children: A review, Nutrients, 5, 2777, 10.3390/nu5072777

Stonehouse, 2014, Does consumption of LC omega-3 PUFA enhance cognitive performance in healthy school-aged children and throughout adulthood? Evidence from clinical trials, Nutrients, 6, 2730, 10.3390/nu6072730

Cederholm, 2013, Omega-3 fatty acids in the prevention of cognitive decline in humans, Adv. Nutr., 4, 672, 10.3945/an.113.004556

Joffre, 2014, n-3 LCPUFA improves cognition: The young, the old and the sick, Prostaglandins Leukot. Essent. Fat. Acids, 91, 1, 10.1016/j.plefa.2014.05.001

Salem, 2015, The benefit of docosahexaenoic acid for the adult brain in aging and dementia, Prostaglandins Leukot. Essent. Fat. Acids, 92, 15, 10.1016/j.plefa.2014.10.003

Sprecher, 1995, Reevaluation of the pathways for the biosynthesis of polyunsaturated fatty acids, J. Lipid Res., 36, 2471, 10.1016/S0022-2275(20)41084-3

Emken, 1994, Dietary linoleic acid influences desaturation and acylation of deuterium-labeled linoleic and linolenic acids in young adult males, Biochim. Biophys. Acta, 1213, 277, 10.1016/0005-2760(94)00054-9

Murphy, 2009, Alpha-linolenic acid and its conversion to longer chain n-3 fatty acids: Benefits for human health and a role in maintaining tissue n-3 fatty acid levels, Prog. Lipid Res., 48, 355, 10.1016/j.plipres.2009.07.002

Brenna, 2009, Alpha-linolenic acid supplementation and conversion to n-3 long-chain polyunsaturated fatty acids in humans, Prostaglandins Leukot. Essent. Fat. Acids, 80, 85, 10.1016/j.plefa.2009.01.004

Salem, 2015, Is the world supply of omega-3 fatty acids adequate for optimal human nutrition?, Curr. Opin. Clin. Nutr. Metab. Care, 18, 147, 10.1097/MCO.0000000000000145

Birch, 2010, The diamond (DHA intake and measurement of neural development) study: A double-masked, randomized controlled clinical trial of the maturation of infant visual acuity as a function of the dietary level of docosahexaenoic acid, Am. J. Clin. Nutr., 91, 848, 10.3945/ajcn.2009.28557

Hoffman, 2009, Toward optimizing vision and cognition in term infants by dietary docosahexaenoic and arachidonic acid supplementation: A review of randomized controlled trials, Prostaglandins Leukot. Essent. Fat. Acids, 81, 151, 10.1016/j.plefa.2009.05.003

Makrides, 2009, Is there a dietary requirement for DHA in pregnancy?, Prostaglandins Leukot. Essent. Fat. Acids, 81, 171, 10.1016/j.plefa.2009.05.005

Brenna, 2007, Docosahexaenoic and arachidonic acid concentrations in human breast milk worldwide, Am. J. Clin. Nutr., 85, 1457, 10.1093/ajcn/85.6.1457

Koletzko, 2008, The roles of long-chain polyunsaturated fatty acids in pregnancy, lactation and infancy: Review of current knowledge and consensus recommendations, J. Perinat. Med., 36, 5, 10.1515/JPM.2008.001

Aranceta, 2012, Recommended dietary reference intakes, nutritional goals and dietary guidelines for fat and fatty acids: A systematic review, Br. J. Nutr., 107, S8, 10.1017/S0007114512001444

Mosca, 2011, Effectiveness-based guidelines for the prevention of cardiovascular disease in women—2011 update: A guideline from the American Heart Association, Circulation, 123, 1243, 10.1161/CIR.0b013e31820faaf8

World Health Organization, and Food and Agriculture Organization of the United Nations (2010). Report of the Joint FAO/WHO Expert Consultation on the Risks and Benefits of Fish Consumption, FAO. FAO Fisheries and Aquaculture Report No. 978.

Blasbalg, 2011, Changes in consumption of omega-3 and omega-6 fatty acids in the United States during the 20th century, Am. J. Clin. Nutr., 93, 950, 10.3945/ajcn.110.006643

Meyer, 2011, Are we consuming enough long chain omega-3 polyunsaturated fatty acids for optimal health?, Prostaglandins Leukot. Essent. Fat. Acids, 85, 275, 10.1016/j.plefa.2011.04.010

Simopoulos, 2011, Evolutionary aspects of diet: The omega-6/omega-3 ratio and the brain, Mol. Neurobiol., 44, 203, 10.1007/s12035-010-8162-0

Broadhurst, 1998, Rift valley lake fish and shellfish provided brain-specific nutrition for early homo, Br. J. Nutr., 79, 3, 10.1079/BJN19980004

Crawford, 1999, Evidence for the unique function of docosahexaenoic acid during the evolution of the modern hominid brain, Lipids, 34, S39, 10.1007/BF02562227

Umhau, 2009, Imaging incorporation of circulating docosahexaenoic acid into the human brain using positron emission tomography, J. Lipid Res., 50, 1259, 10.1194/jlr.M800530-JLR200

Kawashima, 2008, Eicosapentaenoic acid inhibits interleukin-6 production in interleukin-1beta-stimulated C6 glioma cells through peroxisome proliferator-activated receptor-gamma, Prostaglandins Leukot. Essent. Fat. Acids, 79, 59, 10.1016/j.plefa.2008.07.002

Orr, 2013, n-3 polyunsaturated fatty acids in animal models with neuroinflammation, Prostaglandins Leukot. Essent. Fat. Acids, 88, 97, 10.1016/j.plefa.2012.05.008

Chen, 2009, Rapid beta-oxidation of eicosapentaenoic acid in mouse brain: An in situ study, Prostaglandins Leukot. Essent. Fat. Acids, 80, 157, 10.1016/j.plefa.2009.01.005

Ouellet, 2009, Diffusion of docosahexaenoic and eicosapentaenoic acids through the blood-brain barrier: An in situ cerebral perfusion study, Neurochem. Int., 55, 476, 10.1016/j.neuint.2009.04.018

Chen, 2015, Beta-oxidation and rapid metabolism, but not uptake regulate brain eicosapentaenoic acid levels, Prostaglandins Leukot. Essent. Fat. Acids, 92, 33, 10.1016/j.plefa.2014.05.007

Arterburn, 2006, Distribution, interconversion, and dose response of n-3 fatty acids in humans, Am. J. Clin. Nutr., 83, 1467S, 10.1093/ajcn/83.6.1467S

Chen, 2013, The low levels of eicosapentaenoic acid in rat brain phospholipids are maintained via multiple redundant mechanisms, J. Lipid Res., 54, 2410, 10.1194/jlr.M038505

Kaur, 2013, Orally administered [14C] DPA and [14C] DHA are metabolised differently to [14C] EPA in rats, Br. J. Nutr., 109, 441, 10.1017/S0007114512001419

Eaton, 1996, Mammalian mitochondrial beta-oxidation, Biochem. J., 320, 345, 10.1042/bj3200345

Reddy, 2001, Peroxisomal beta-oxidation and peroxisome proliferator-activated receptor alpha: An adaptive metabolic system, Annu. Rev. Nutr., 21, 193, 10.1146/annurev.nutr.21.1.193

Morse, 2012, Benefits of docosahexaenoic acid, folic acid, vitamin D and iodine on foetal and infant brain development and function following maternal supplementation during pregnancy and lactation, Nutrients, 4, 799, 10.3390/nu4070799

Lin, 2010, Compartmental analyses of 2H5-alpha-linolenic acid and CU-eicosapentaenoic acid toward synthesis of plasma labeled 22:6n-3 in newborn term infants, Am. J. Clin. Nutr., 92, 284, 10.3945/ajcn.2009.28779

Pawlosky, 2004, Perspectives on alcohol consumption: Liver polyunsaturated fatty acids and essential fatty acid metabolism, Alcohol, 34, 27, 10.1016/j.alcohol.2004.07.009

Plourde, 2007, Extremely limited synthesis of long chain polyunsaturates in adults: Implications for their dietary essentiality and use as supplements, Appl. Physiol. Nutr. Metab., 32, 619, 10.1139/H07-034

Egert, 2012, Margarines fortified with alpha-linolenic acid, eicosapentaenoic acid, or docosahexaenoic acid alter the fatty acid composition of erythrocytes but do not affect the antioxidant status of healthy adults, J. Nutr., 142, 1638, 10.3945/jn.112.161802

Carver, 2001, The relationship between age and the fatty acid composition of cerebral cortex and erythrocytes in human subjects, Brain Res. Bull., 56, 79, 10.1016/S0361-9230(01)00551-2

Martinez, 1992, Tissue levels of polyunsaturated fatty acids during early human development, J. Pediatr., 120, S129, 10.1016/S0022-3476(05)81247-8

Bourre, 2006, Effects of nutrients (in food) on the structure and function of the nervous system: Update on dietary requirements for brain. Part 1: Micronutrients, J. Nutr. Health Aging, 10, 377

McNamara, 2006, Role of omega-3 fatty acids in brain development and function: Potential implications for the pathogenesis and prevention of psychopathology, Prostaglandins Leukot. Essent. Fat. Acids, 75, 329, 10.1016/j.plefa.2006.07.010

Chen, C.T., Kitson, A.P., Hopperton, K.E., Domenichiello, A.F., Trepanier, M.O., Lin, L.E., Ermini, L., Post, M., Thies, F., and Bazinet, R.P. (2015). Plasma non-esterified docosahexaenoic acid is the major pool supplying the brain. Sci. Rep., 5.

DeMar, 2005, Alpha-linolenic acid does not contribute appreciably to docosahexaenoic acid within brain phospholipids of adult rats fed a diet enriched in docosahexaenoic acid, J. Neurochem., 94, 1063, 10.1111/j.1471-4159.2005.03258.x

Pachiaudi, 1999, Blood compartmental metabolism of docosahexaenoic acid (DHA) in humans after ingestion of a single dose of [13C] DHA in phosphatidylcholine, J. Lipid Res., 40, 1867, 10.1016/S0022-2275(20)34903-8

Chen, 2013, Regioisomers of phosphatidylcholine containing DHA and their potential to deliver DHA to the brain: Role of phospholipase specificities, Lipids, 48, 675, 10.1007/s11745-013-3791-5

Liu, 2010, Fatty acid binding proteins in brain development and disease, Int. J. Dev. Biol., 54, 1229, 10.1387/ijdb.092976rl

Pan, 2015, Fatty acid-binding protein 5 facilitates the blood-brain barrier transport of docosahexaenoic acid, Mol. Pharm., 12, 4375, 10.1021/acs.molpharmaceut.5b00580

Vandal, 2014, Reduction in DHA transport to the brain of mice expressing human APOE4 compared to APOE 2, J. Neurochem., 129, 516, 10.1111/jnc.12640

Chen, 2008, Regulation of brain polyunsaturated fatty acid uptake and turnover, Prostaglandins Leukot. Essent. Fat. Acids, 79, 85, 10.1016/j.plefa.2008.09.003

Kennedy, 1956, The function of cytidine coenzymes in the biosynthesis of phospholipides, J. Biol. Chem., 222, 193, 10.1016/S0021-9258(19)50785-2

Jensen, 2009, Docosahexaenoic acid and lactation, Prostaglandins Leukot. Essent. Fat. Acids, 81, 175, 10.1016/j.plefa.2009.05.006

Simmer, K., Patole, S.K., and Rao, S.C. (2011). Long-chain polyunsaturated fatty acid supplementation in infants born at term. Cochrane Database Syst. Rev.

Chambaz, 1985, Essential fatty acids interconversion in the human fetal liver, Biol. Neonate, 47, 136, 10.1159/000242104

Innis, 2005, Essential fatty acid transfer and fetal development, Placenta, 26, S70, 10.1016/j.placenta.2005.01.005

Uauy, 2000, Essential fatty acids in early life: Structural and functional role, Proc. Nutr. Soc., 59, 3, 10.1017/S0029665100000021

Cheung, 2007, Developmental potential in the first 5 years for children in developing countries, Lancet, 369, 60, 10.1016/S0140-6736(07)60032-4

Farquharson, 1992, Infant cerebral cortex phospholipid fatty-acid composition and diet, Lancet, 340, 810, 10.1016/0140-6736(92)92684-8

Makrides, 1995, Are long-chain polyunsaturated fatty acids essential nutrients in infancy?, Lancet, 345, 1463, 10.1016/S0140-6736(95)91035-2

European Food Safety Authority (2010). Scientific opinion on dietary reference values for fats, including saturated fatty acids, polyunsaturated fatty acids, monounsaturated fatty acids, trans fatty acids, and cholesterol. EFSA J., 8, 1461.

Makrides, M., Duley, L., and Olsen, S.F. (2006). Marine oil, and other prostaglandin precursor, supplementation for pregnancy uncomplicated by pre-eclampsia or intrauterine growth restriction. Cochrane Database Syst Rev., 3.

Szajewska, 2006, Effect of n-3 long-chain polyunsaturated fatty acid supplementation of women with low-risk pregnancies on pregnancy outcomes and growth measures at birth: A meta-analysis of randomized controlled trials, Am. J. Clin. Nutr., 83, 1337, 10.1093/ajcn/83.6.1337

Horvath, 2007, Effect of supplementation of women in high-risk pregnancies with long-chain polyunsaturated fatty acids on pregnancy outcomes and growth measures at birth: A meta-analysis of randomized controlled trials, Br. J. Nutr., 98, 253, 10.1017/S0007114507709078

Ramakrishnan, 2010, Effects of docosahexaenoic acid supplementation during pregnancy on gestational age and size at birth: Randomized, double-blind, placebo-controlled trial in Mexico, Food Nutr. Bull., 31, S108, 10.1177/15648265100312S203

Hibbeln, 2007, Maternal seafood consumption in pregnancy and neurodevelopmental outcomes in childhood (ALSPAC study): An observational cohort study, Lancet, 369, 578, 10.1016/S0140-6736(07)60277-3

Jensen, 2010, Effects of early maternal docosahexaenoic acid intake on neuropsychological status and visual acuity at five years of age of breast-fed term infants, J. Pediatr., 157, 900, 10.1016/j.jpeds.2010.06.006

Makrides, 2010, Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: A randomized controlled trial, JAMA, 304, 1675, 10.1001/jama.2010.1507

Belfort, 2013, Infant feeding and childhood cognition at ages 3 and 7 years: Effects of breastfeeding duration and exclusivity, JAMA Pediatr., 167, 836, 10.1001/jamapediatrics.2013.455

Hoddinott, 2008, Breast feeding, BMJ, 336, 881, 10.1136/bmj.39521.566296.BE

Jensen, 2005, Effects of maternal docosahexaenoic acid intake on visual function and neurodevelopment in breastfed term infants, Am. J. Clin. Nutr., 82, 125, 10.1093/ajcn/82.1.125

Uauy, 2003, Term infant studies of DHA and ara supplementation on neurodevelopment: Results of randomized controlled trials, J. Pediatr., 143, S17, 10.1067/S0022-3476(03)00398-6

Walker, 2007, Child development: Risk factors for adverse outcomes in developing countries, Lancet, 369, 145, 10.1016/S0140-6736(07)60076-2

Hart, 2006, Brief report: Newborn behavior differs with decosahexaenoic acid levels in breast milk, J. Pediatr. Psychol., 31, 221, 10.1093/jpepsy/jsj069

Decsi, 2005, Effect of n-3 polyunsaturated fatty acid supplementation in pregnancy: The nuheal trial, Adv. Exp. Med. Biol., 569, 109, 10.1007/1-4020-3535-7_15

Helland, 2003, Maternal supplementation with very-long-chain n-3 fatty acids during pregnancy and lactation augments children’s IQ at 4 years of age, Pediatrics, 111, e39, 10.1542/peds.111.1.e39

Boucher, 2011, Neurophysiologic and neurobehavioral evidence of beneficial effects of prenatal omega-3 fatty acid intake on memory function at school age, Am. J. Clin. Nutr., 93, 1025, 10.3945/ajcn.110.000323

Innis, 2014, Impact of maternal diet on human milk composition and neurological development of infants, Am. J. Clin. Nutr., 99, 734S, 10.3945/ajcn.113.072595

Agostoni, C., Brunetti, I., and Marco, A.D. (2005). Polyunsaturated fatty acids in development in breastfed infants human and neurological. Curr. Pediatr. Rev., 25–30.

Gibson, 1997, Effect of increasing breast milk docosahexaenoic acid on plasma and erythrocyte phospholipid fatty acids and neural indices of exclusively breast fed infants, Eur. J. Clin. Nutr., 51, 578, 10.1038/sj.ejcn.1600446

Innis, 2007, Dietary (n-3) fatty acids and brain development, J. Nutr., 137, 855, 10.1093/jn/137.4.855

Horta, B., Bahl, R., Martines, J., and Victora, C. (2007). Evidence on the Long-Term Effects of Breastfeeding, WHO.

Oddy, 2010, The long-term effects of breastfeeding on child and adolescent mental health: A pregnancy cohort study followed for 14 years, J. Pediatr., 156, 568, 10.1016/j.jpeds.2009.10.020

Eilander, 2007, Effects of n-3 long chain polyunsaturated fatty acid supplementation on visual and cognitive development throughout childhood: A review of human studies, Prostaglandins Leukot. Essent. Fat. Acids, 76, 189, 10.1016/j.plefa.2007.01.003

Drover, 2011, Cognitive function in 18-month-old term infants of the diamond study: A randomized, controlled clinical trial with multiple dietary levels of docosahexaenoic acid, Early Hum. Dev., 87, 223, 10.1016/j.earlhumdev.2010.12.047

Meldrum, 2012, Effects of high-dose fish oil supplementation during early infancy on neurodevelopment and language: A randomised controlled trial, Br. J. Nutr., 108, 1443, 10.1017/S0007114511006878

Birch, 2007, Visual acuity and cognitive outcomes at 4 years of age in a double-blind, randomized trial of long-chain polyunsaturated fatty acid-supplemented infant formula, Early Hum. Dev., 83, 279, 10.1016/j.earlhumdev.2006.11.003

Makrides, 2000, A randomized trial of different ratios of linoleic to alpha-linolenic acid in the diet of term infants: Effects on visual function and growth, Am. J. Clin. Nutr., 71, 120, 10.1093/ajcn/71.1.120

Cohen, 2005, A quantitative analysis of prenatal intake of n-3 polyunsaturated fatty acids and cognitive development, Am. J. Prev. Med., 29, 366, 10.1016/j.amepre.2005.06.008

Tofail, 2006, Supplementation of fish-oil and soy-oil during pregnancy and psychomotor development of infants, J. Health Popul. Nutr., 24, 48

Dunstan, 2008, Cognitive assessment of children at age 2 (1/2) years after maternal fish oil supplementation in pregnancy: A randomised controlled trial, Arch. Dis. Child. Fetal Neonatal Ed., 93, F45, 10.1136/adc.2006.099085

Scott, D.T., Janowsky, J.S., Carroll, R.E., Taylor, J.A., Auestad, N., and Montalto, M.B. (1998). Formula supplementation with long-chain polyunsaturated fatty acids: Are there developmental benefits?. Pediatrics, 102.

Hoffman, 1992, Essentiality of dietary omega 3 fatty acids for premature infants: Plasma and red blood cell fatty acid composition, Lipids, 27, 886, 10.1007/BF02535868

Fewtrell, 2004, Randomized, double-blind trial of long-chain polyunsaturated fatty acid supplementation with fish oil and borage oil in preterm infants, J. Pediatr., 144, 471, 10.1016/j.jpeds.2004.01.034

Clandinin, 2005, Growth and development of preterm infants fed infant formulas containing docosahexaenoic acid and arachidonic acid, J. Pediatr., 146, 461, 10.1016/j.jpeds.2004.11.030

Henriksen, 2008, Improved cognitive development among preterm infants attributable to early supplementation of human milk with docosahexaenoic acid and arachidonic acid, Pediatrics, 121, 1137, 10.1542/peds.2007-1511

Makrides, 2011, Impact of fatty acid status on growth and neurobehavioural development in humans, Mater. Child Nutr., 7, 80, 10.1111/j.1740-8709.2011.00304.x

Makrides, 2009, Neurodevelopmental outcomes of preterm infants fed high-dose docosahexaenoic acid: A randomized controlled trial, JAMA, 301, 175, 10.1001/jama.2008.945

Collins, C.T., Gibson, R.A., Anderson, P.J., McPhee, A.J., Sullivan, T.R., Gould, J.F., Ryan, P., Doyle, L.W., Davis, P.G., and McMichael, J.E. (2015). Neurodevelopmental outcomes at 7 years’ corrected age in preterm infants who were fed high-dose docosahexaenoic acid to term equivalent: A follow-up of a randomised controlled trial. BMJ Open, 5.

Molloy, 2016, Long-term effect of high-dose supplementation with DHA on visual function at school age in children born at <33 wk gestational age: Results from a follow-up of a randomized controlled trial, Am. J. Clin. Nutr., 103, 268, 10.3945/ajcn.115.114710

Prentice, 2011, Impact of fatty acid status on immune function of children in low-income countries, Mater. Child Nutr., 7, 89, 10.1111/j.1740-8709.2011.00313.x

Scholtz, 2013, Clinical overview of effects of dietary long-chain polyunsaturated fatty acids during the perinatal period, Nestle Nutr. Inst. Workshop Ser., 77, 145, 10.1159/000351397

Delgado-Noguera, M.F., Calvache, J.A., Bonfill Cosp, X., Kotanidou, E.P., and Galli-Tsinopoulou, A. (2015). Supplementation with long chain polyunsaturated fatty acids (LCPUFA) to breastfeeding mothers for improving child growth and development. Cochrane Database Syst. Rev., 7.

Michaelsen, 2011, Food sources and intake of n-6 and n-3 fatty acids in low-income countries with emphasis on infants, young children (6–24 months), and pregnant and lactating women, Mater. Child Nutr., 7, 124, 10.1111/j.1740-8709.2011.00302.x

Barbarich, 2006, Polyunsaturated fatty acids and anthropometric indices of children in rural China, Eur. J. Clin. Nutr., 60, 1100, 10.1038/sj.ejcn.1602424

Yakes, 2011, Intakes and breast-milk concentrations of essential fatty acids are low among Bangladeshi women with 24–48-month-old children, Br. J. Nutr., 105, 1660, 10.1017/S0007114510004964

Huybregts, 2009, Dietary behaviour, food and nutrient intake of pregnant women in a rural community in Burkina Faso, Mater. Child Nutr., 5, 211, 10.1111/j.1740-8709.2008.00180.x

Mardones, 2008, Effects of a dairy product fortified with multiple micronutrients and omega-3 fatty acids on birth weight and gestation duration in pregnant Chilean women, Public Health Nutr., 11, 30, 10.1017/S1368980007000110

Muthayya, 2009, Effect of fortification with multiple micronutrients and n-3 fatty acids on growth and cognitive performance in Indian schoolchildren: The champion (children’s health and mental performance influenced by optimal nutrition) study, Am. J. Clin. Nutr., 89, 1766, 10.3945/ajcn.2008.26993

Osendarp, 2007, Effect of a 12-mo micronutrient intervention on learning and memory in well-nourished and marginally nourished school-aged children: 2 parallel, randomized, placebo-controlled studies in Australia and Indonesia, Am. J. Clin. Nutr., 86, 1082, 10.1093/ajcn/86.4.1082

Dalton, 2009, A randomised control trial in schoolchildren showed improvement in cognitive function after consuming a bread spread, containing fish flour from a marine source, Prostaglandins Leukot. Essent. Fat. Acids, 80, 143, 10.1016/j.plefa.2008.12.006

Stevens, 1996, Omega-3 fatty acids in boys with behavior, learning, and health problems, Physiol. Behav., 59, 915, 10.1016/0031-9384(95)02207-4

McNamara, 2010, Docosahexaenoic acid supplementation increases prefrontal cortex activation during sustained attention in healthy boys: A placebo-controlled, dose-ranging, functional magnetic resonance imaging study, Am. J. Clin. Nutr., 91, 1060, 10.3945/ajcn.2009.28549

Richardson, A.J., Burton, J.R., Sewell, R.P., Spreckelsen, T.F., and Montgomery, P. (2012). Docosahexaenoic acid for reading, cognition and behavior in children aged 7–9 years: A randomized, controlled trial (the DOLAB study). PLoS ONE, 7.

Brew, 2015, Omega-3 supplementation during the first 5 years of life and later academic performance: A randomised controlled trial, Eur. J. Clin. Nutr., 69, 419, 10.1038/ejcn.2014.155

Lassek, W.D., and Gaulin, S.J.C. (2011). Sex differences in the relationship of dietary fatty acids to cognitive measures in American children. Front. Evol. Neurosci., 3.

Extier, 2010, Gender affects liver desaturase expression in a rat model of n-3 fatty acid repletion, J. Nutr. Biochem., 21, 180, 10.1016/j.jnutbio.2008.10.008

Schram, 2007, Food matrices affect the bioavailability of (n-3) polyunsaturated fatty acids in a single meal study in humans, Food Res. Int., 40, 1062, 10.1016/j.foodres.2007.06.005

Ulven, 2011, Metabolic effects of krill oil are essentially similar to those of fish oil but at lower dose of EPA and DHA, in healthy volunteers, Lipids, 46, 37, 10.1007/s11745-010-3490-4

Elvevoll, 2006, Enhanced incorporation of n-3 fatty acids from fish compared with fish oils, Lipids, 41, 1109, 10.1007/s11745-006-5060-3

Arterburn, 2007, Bioequivalence of docosahexaenoic acid from different algal oils in capsules and in a DHA -fortified food, Lipids, 42, 1011, 10.1007/s11745-007-3098-5

Kuratko, 2009, Biomarkers of DHA status, Prostaglandins Leukot. Essent. Fat. Acids, 81, 111, 10.1016/j.plefa.2009.05.007

Elshorbagy, 2015, Brain atrophy in cognitively impaired elderly: The importance of long-chain ω-3 fatty acids and B vitamin status in a randomized controlled trial, Am. J. Clin. Nutr., 102, 215, 10.3945/ajcn.114.103283

McCann, 2005, Is docosahexaenoic acid, an n-3 long-chain polyunsaturated fatty acid, required for development of normal brain function? An overview of evidence from cognitive and behavioral tests in humans and animals, Am. J. Clin. Nutr., 82, 281, 10.1093/ajcn/82.2.281

Fleith, 2005, Dietary pufa for preterm and term infants: Review of clinical studies, Crit. Rev. Food Sci Nutr., 45, 205, 10.1080/10408690590956378

Innis, 2007, Fatty acids and early human development, Early Hum. Dev., 83, 761, 10.1016/j.earlhumdev.2007.09.004

Youdim, 2000, Essential fatty acids and the brain: Possible health implications, Int. J. Dev. Neurosci., 18, 383, 10.1016/S0736-5748(00)00013-7

Liu, 2000, Docosahexaenoic acid, a ligand for the retinoid X receptor in mouse brain, Science, 290, 2140, 10.1126/science.290.5499.2140

Kitajka, 2004, Effects of dietary omega-3 polyunsaturated fatty acids on brain gene expression, Proc. Natl. Acad. Sci. USA, 101, 10931, 10.1073/pnas.0402342101

Calderon, 2004, Docosahexaenoic acid promotes neurite growth in hippocampal neurons, J. Neurochem., 90, 979, 10.1111/j.1471-4159.2004.02520.x

Moriguchi, 2000, Behavioral deficits associated with dietary induction of decreased brain docosahexaenoic acid concentration, J. Neurochem., 75, 2563, 10.1046/j.1471-4159.2000.0752563.x

Lingwood, 2008, MAP2 provides reliable early assessment of neural injury in the newborn piglet model of birth asphyxia, J. Neurosci. Methods, 171, 140, 10.1016/j.jneumeth.2008.02.011

Shaikh, 2004, Oleic and docosahexaenoic acid differentially phase separate from lipid raft molecules: A comparative NMR, DSC, AFM, and detergent extraction study, Biophys. J., 87, 1752, 10.1529/biophysj.104.044552

Stillwell, 2005, Docosahexaenoic acid affects cell signaling by altering lipid rafts, Reprod. Nutr. Dev., 45, 559, 10.1051/rnd:2005046

Vinson, 2003, Lipid rafts mediate the interaction between myelin-associated glycoprotein (MAG) on myelin and MAG-receptors on neurons, Mol. Cell. Neurosci., 22, 344, 10.1016/S1044-7431(02)00031-3

Jaworski, 2006, The growing role of mtor in neuronal development and plasticity, Mol. Neurobiol., 34, 205, 10.1385/MN:34:3:205

Jin, 2012, Atorvastatin enhances neurite outgrowth in cortical neurons in vitro via up-regulating the Akt/mTOR and Akt/GSK-3beta signaling pathways, Acta Pharmacol. Sin., 33, 861, 10.1038/aps.2012.59

Cao, 2009, Docosahexaenoic acid promotes hippocampal neuronal development and synaptic function, J. Neurochem., 111, 510, 10.1111/j.1471-4159.2009.06335.x

Darios, 2006, Omega-3 and omega-6 fatty acids stimulate cell membrane expansion by acting on syntaxin 3, Nature, 440, 813, 10.1038/nature04598

Nyaradi, 2013, The role of nutrition in children’s neurocognitive development, from pregnancy through childhood, Front. Hum. Neurosci., 7, 97, 10.3389/fnhum.2013.00097

Bourre, 1984, Alterations in the fatty acid composition of rat brain cells (neurons, astrocytes, and oligodendrocytes) and of subcellular fractions (myelin and synaptosomes) induced by a diet devoid of n-3 fatty acids, J. Neurochem., 43, 342, 10.1111/j.1471-4159.1984.tb00906.x

Ikemoto, 2001, Reversibility of n-3 fatty acid deficiency-induced alterations of learning behavior in the rat: Level of n-6 fatty acids as another critical factor, J. Lipid Res., 42, 1655, 10.1016/S0022-2275(20)32220-3

Brenna, 2011, Animal studies of the functional consequences of suboptimal polyunsaturated fatty acid status during pregnancy, lactation and early post-natal life, Mater. Child Nutr., 7, 59, 10.1111/j.1740-8709.2011.00301.x

Diau, G.Y., Hsieh, A.T., Sarkadi-Nagy, E.A., Wijendran, V., Nathanielsz, P.W., and Brenna, J.T. (2005). The influence of long chain polyunsaturate supplementation on docosahexaenoic acid and arachidonic acid in baboon neonate central nervous system. BMC Med., 3.

Luchtman, 2013, Cognitive enhancement by omega-3 fatty acids from child-hood to old age: Findings from animal and clinical studies, Neuropharmacology, 64, 550, 10.1016/j.neuropharm.2012.07.019

Neuringer, 1986, Biochemical and functional effects of prenatal and postnatal omega 3 fatty acid deficiency on retina and brain in rhesus monkeys, Proc. Natl. Acad. Sci. USA, 83, 4021, 10.1073/pnas.83.11.4021

Champoux, 2002, Fatty acid formula supplementation and neuromotor development in rhesus monkey neonates, Pediatr. Res., 51, 273, 10.1203/00006450-200203000-00003

Greiner, 1999, Rats with low levels of brain docosahexaenoic acid show impaired performance in olfactory-based and spatial learning tasks, Lipids, 34, S239, 10.1007/BF02562305

Novak, 2008, High dietary omega-6 fatty acids contribute to reduced docosahexaenoic acid in the developing brain and inhibit secondary neurite growth, Brain Res., 1237, 136, 10.1016/j.brainres.2008.07.107

Abubakari, 2014, Omega-3 fatty acid supplementation and cognitive function: Are smaller dosages more beneficial?, Int. J. Gen. Med., 7, 463

Jiao, 2014, Effect of n-3 PUFA supplementation on cognitive function throughout the life span from infancy to old age: A systematic review and meta-analysis of randomized controlled trials, Am. J. Clin. Nutr., 100, 1422, 10.3945/ajcn.114.095315

Yurko-Mauro, K., Alexander, D.D., and van Elswyk, M.E. (2015). Docosahexaenoic acid and adult memory: A systematic review and meta-analysis. PLoS ONE, 10.

Muldoon, 2010, Serum phospholipid docosahexaenonic acid is associated with cognitive functioning during middle adulthood, J. Nutr., 140, 848, 10.3945/jn.109.119578

Leckie, 2014, Omega-3 fatty acids moderate effects of physical activity on cognitive function, Neuropsychologia, 59, 103, 10.1016/j.neuropsychologia.2014.04.018

Erickson, 2011, Exercise training increases size of hippocampus and improves memory, Proc. Natl. Acad. Sci. USA, 108, 3017, 10.1073/pnas.1015950108

Erickson, 2012, Physical activity, brain plasticity, and Alzheimer’s disease, Arch. Med. Res., 43, 615, 10.1016/j.arcmed.2012.09.008

Rogers, 2008, No effect of n-3 long-chain polyunsaturated fatty acid (EPA and DHA) supplementation on depressed mood and cognitive function: A randomised controlled trial, Br. J. Nutr., 99, 421, 10.1017/S0007114507801097

Jackson, 2012, No effect of 12 weeks’ supplementation with 1 g DHA -rich or EPA-rich fish oil on cognitive function or mood in healthy young adults aged 18–35 years, Br. J. Nutr., 107, 1232, 10.1017/S000711451100403X

Antypa, 2009, Omega-3 fatty acids (fish-oil) and depression-related cognition in healthy volunteers, J. Psychopharmacol., 23, 831, 10.1177/0269881108092120

Karr, 2012, Omega-3 polyunsaturated fatty acids and cognition in a college-aged population, Exp. Clin. Psychopharmacol., 20, 236, 10.1037/a0026945

Stonehouse, 2013, DHA supplementation improved both memory and reaction time in healthy young adults: A randomized controlled trial, Am. J. Clin. Nutr., 94, 1134, 10.3945/ajcn.112.053371

Duff, 2001, A sex difference on a novel spatial working memory task in humans, Brain Cogn., 47, 470, 10.1006/brcg.2001.1326

Halpern, 2000, Mapping cognitive processes onto the brain: Mind the gap, Brain Cogn., 42, 128, 10.1006/brcg.1999.1181

Jaremka, 2014, Omega-3 supplementation and loneliness-related memory problems, Psychosom. Med., 76, 650, 10.1097/PSY.0000000000000104

Services, H. (2011). Global Health and Aging, National Institutes of Health.

Resnick, 2003, Longitudinal magnetic resonance imaging studies of older adults: A shrinking brain, J. Neurosci., 23, 3295, 10.1523/JNEUROSCI.23-08-03295.2003

McNamara, 2008, The aging human orbitofrontal cortex: Decreasing polyunsaturated fatty acid composition and associated increases in lipogenic gene expression and stearoyl-CoA desaturase activity, Prostaglandins Leukot. Essent. Fat. Acids, 78, 293, 10.1016/j.plefa.2008.04.001

Andre, 2006, Plasmalogen metabolism-related enzymes in rat brain during aging: Influence of n-3 fatty acid intake, Biochimie, 88, 103, 10.1016/j.biochi.2005.06.010

Giusto, 2002, Age-associated changes in central nervous system glycerolipid composition and metabolism, Neurochem. Res., 27, 1513, 10.1023/A:1021604623208

Plourde, M., Chouinard-Watkins, R., Vandal, M., Zhang, Y., Lawrence, P., Brenna, J.T., and Cunnane, S.C. (2011). Plasma incorporation, apparent retroconversion and beta-oxidation of 13c-docosahexaenoic acid in the elderly. Nutr. Metab., 8.

Conklin, 2007, Long-chain omega-3 fatty acid intake is associated positively with corticolimbic gray matter volume in healthy adults, Neurosci. Lett., 421, 209, 10.1016/j.neulet.2007.04.086

Raji, 2014, Regular fish consumption and age-related brain gray matter loss, Am. J. Prev. Med., 47, 444, 10.1016/j.amepre.2014.05.037

Masliah, 2006, Synaptic remodeling during aging and in Alzheimer’s disease, J. Alzheimer’s Dis., 9, 91, 10.3233/JAD-2006-9S311

Jorm, 1998, The incidence of dementia: A meta-analysis, Neurology, 51, 728, 10.1212/WNL.51.3.728

Mohajeri, 2015, Inadequate supply of vitamins and DHA in the elderly: Implications for brain aging and Alzheimer-type dementia, Nutrition, 31, 261, 10.1016/j.nut.2014.06.016

Reiman, 2012, Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer’s disease in the presenilin 1 E280A kindred: A case-control study, Lancet Neurol., 11, 1048, 10.1016/S1474-4422(12)70228-4

Ellinson, 2004, A critical evaluation of the relationship between serum vitamin B, folate and total homocysteine with cognitive impairment in the elderly, J. Hum. Nutr. Diet., 17, 371, 10.1111/j.1365-277X.2004.00532.x

Adunsky, 2005, Plasma homocysteine levels and cognitive status in long-term stay geriatric patients: A cross-sectional study, Arch. Gerontol. Geriatr., 40, 129, 10.1016/j.archger.2004.07.001

Terry, 2000, Cell death or synaptic loss in Alzheimer disease, J. Neuropathol. Exp. Neurol., 59, 1118, 10.1093/jnen/59.12.1118

Vida, 2014, Increase of oxidation and inflammation in nervous and immune systems with aging and anxiety, Curr. Pharm. Des., 20, 4656, 10.2174/1381612820666140130201734

Kalmijn, 2004, Dietary intake of fatty acids and fish in relation to cognitive performance at middle age, Neurology, 62, 275, 10.1212/01.WNL.0000103860.75218.A5

Tijhuis, 2007, Fish consumption, n-3 fatty acids, and subsequent 5-y cognitive decline in elderly men: The Zutphen elderly study, Am. J. Clin. Nutr., 85, 1142, 10.1093/ajcn/85.4.1142

Eskelinen, 2008, Fat intake at midlife and cognitive impairment later in life: A population-based caide study, Int. J. Geriatr. Psychiatry, 23, 741, 10.1002/gps.1969

Velho, 2008, Dietary intake adequacy and cognitive function in free-living active elderly: A cross-sectional and short-term prospective study, Clin. Nutr., 27, 77, 10.1016/j.clnu.2007.10.011

Huerta, 2010, The relationship between dietary lipids and cognitive performance in an elderly population, Int. J. Food Sci. Nutr., 61, 217, 10.3109/09637480903348098

Gao, 2011, Omega-3 polyunsaturated fatty acid supplements and cognitive decline: Singapore longitudinal aging studies, J. Nutr. Health Aging, 15, 32, 10.1007/s12603-011-0010-z

Titova, 2013, Dietary intake of eicosapentaenoic and docosahexaenoic acids is linked to gray matter volume and cognitive function in elderly, Age, 35, 1495, 10.1007/s11357-012-9453-3

Qin, 2014, Fish intake is associated with slower cognitive decline in Chinese older adults, J. Nutr., 144, 1579, 10.3945/jn.114.193854

Mera, 2016, Oily fish intake and cognitive performance in community-dwelling older adults: The Atahualpa project, J. Community Health, 41, 82, 10.1007/s10900-015-0070-9

Archer, 2015, The inadmissibility of what we eat in America and nhanes dietary data in nutrition and obesity research and the scientific formulation of national dietary guidelines, Mayo Clin. Proc., 90, 911, 10.1016/j.mayocp.2015.04.009

Ammann, 2013, Omega-3 fatty acids and domain-specific cognitive aging: Secondary analyses of data from WHISCA, Neurology, 81, 1484, 10.1212/WNL.0b013e3182a9584c

Heude, 2003, Cognitive decline and fatty acid composition of erythrocyte membranes—The EVA study, Am. J. Clin. Nutr., 77, 803, 10.1093/ajcn/77.4.803

Dullemeijer, 2007, n-3 fatty acid proportions in plasma and cognitive performance in older adults, Am. J. Clin. Nutr., 86, 1479, 10.1093/ajcn/86.5.1479

Whalley, 2008, n-3 fatty acid erythrocyte membrane content, APOEe4, and cognitive variation: An observational follow-up study in late adulthood, Am. J. Clin. Nutr., 87, 449, 10.1093/ajcn/87.2.449

Tan, 2012, Red blood cell ω-3 fatty acid levels and markers of accelerated brain aging, Neurology, 78, 658, 10.1212/WNL.0b013e318249f6a9

Baierle, 2014, Fatty acid status and its relationship to cognitive decline and homocysteine levels in the elderly, Nutrients, 6, 3624, 10.3390/nu6093624

Otsuka, 2014, Serum docosahexaenoic and eicosapentaenoic acid and risk of cognitive decline over 10 years among elderly Japanese, Eur. J. Clin. Nutr., 68, 503, 10.1038/ejcn.2013.264

Dangour, 2010, Effect of 2-y n-3 long-chain polyunsaturated fatty acid supplementation on cognitive function in older people: A randomized, double-blind, controlled trial, Am. J. Clin. Nutr., 91, 1725, 10.3945/ajcn.2009.29121

Geleijnse, 2008, Effect of fish oil on cognitive performance in older subjects: A randomized, controlled trial, Neurology, 71, 430, 10.1212/01.wnl.0000324268.45138.86

Stough, 2012, The effects of 90-day supplementation with the omega-3 essential fatty acid docosahexaenoic acid (DHA) on cognitive function and visual acuity in a healthy aging population, Neurobiol. Aging, 33, e821, 10.1016/j.neurobiolaging.2011.03.019

Johnson, 2008, Cognitive findings of an exploratory trial of docosahexaenoic acid and lutein supplementation in older women, Nutr. Neurosci., 11, 75, 10.1179/147683008X301450

McCarthy, 2010, Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline, Alzheimer’s Dement., 6, 456, 10.1016/j.jalz.2010.01.013

Vakhapova, 2014, Phosphatidylserine containing omega-3 fatty acids may improve memory abilities in nondemented elderly individuals with memory complaints: Results from an open-label extension study, Dement. Geriatr. Cogn. Disord., 38, 39, 10.1159/000357793

Vakhapova, 2010, Phosphatidylserine containing ω–3 fatty acids may improve memory abilities in non-demented elderly with memory complaints: A double-blind placebo-controlled trial, Dement. Geriatr. Cogn. Disord., 29, 467, 10.1159/000310330

Nilsson, A., Radeborg, K., Salo, I., and Bjorck, I. (2012). Effects of supplementation with n-3 polyunsaturated fatty acids on cognitive performance and cardiometabolic risk markers in healthy 51 to 72 years old subjects: A randomized controlled cross-over study. Nutr. J., 11.

Tokuda, 2015, Low doses of long-chain polyunsaturated fatty acids affect cognitive function in elderly Japanese men: A randomized controlled trial, J. Oleo Sci., 2015, 1

Ito, 1991, Auditory event-related potentials (ERPs) in healthy subjects and patients with dementia, Jpn. J. Clin. Path. (Rinsho Byori)., 39, 859

Strike, 2016, A high omega-3 fatty acid multinutrient supplement benefits cognition and mobility in older women: A randomized, double-blind, placebo-controlled pilot study, J. Gerontol. Ser. A Biol. Sci. Med. Sci., 71, 236, 10.1093/gerona/glv109

Maestre, 2012, Assessing dementia in resource-poor regions, Curr. Neurol. Neurosci. Rep., 12, 511, 10.1007/s11910-012-0300-9

Deary, 2009, Age-associated cognitive decline, Br. Med. Bull., 92, 135, 10.1093/bmb/ldp033

Scahill, 2003, A longitudinal study of brain volume changes in normal aging using serial registered magnetic resonance imaging, Arch. Neurol., 60, 989, 10.1001/archneur.60.7.989

Risacher, 2009, Baseline MRI predictors of conversion from MCI to probable AD in the ADNI cohort, Curr. Alzheimer Res., 6, 347, 10.2174/156720509788929273

Kalpouzos, 2005, Working memory and FDG-PET dissociate early and late onset Alzheimer disease patients, J. Neurol., 252, 548, 10.1007/s00415-005-0685-3

Landau, 2011, Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI, Neurobiol. Aging, 32, 1207, 10.1016/j.neurobiolaging.2009.07.002

Nugent, 2014, Brain glucose and acetoacetate metabolism: A comparison of young and older adults, Neurobiol. Aging, 35, 1386, 10.1016/j.neurobiolaging.2013.11.027

Hooijmans, 2012, The effects of long-term omega-3 fatty acid supplementation on cognition and Alzheimer’s pathology in animal models of Alzheimer’s disease: A systematic review and meta-analysis, J. Alzheimer’s Dis., 28, 191, 10.3233/JAD-2011-111217

Richard, 2012, Methodological challenges in designing dementia prevention trials—The European dementia prevention initiative (EDPI), J. Neurol. Sci., 322, 64, 10.1016/j.jns.2012.06.012

Albanese, 2009, Dietary fish and meat intake and dementia in latin America, China, and India: A 10/66 dementia research group population-based study, Am. J. Clin. Nutr., 90, 392, 10.3945/ajcn.2009.27580

Raffaitin, 2007, Dietary patterns and risk of dementia, Neurology, 69, 1921, 10.1212/01.wnl.0000278116.37320.52

Schaefer, 2006, Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: The Framingham heart study, Arch. Neurol., 63, 1545, 10.1001/archneur.63.11.1545

Wu, 2015, Omega-3 fatty acids intake and risks of dementia and Alzheimer’s disease: A meta-analysis, Neurosci. Biobehav. Rev., 48, 1, 10.1016/j.neubiorev.2014.11.008

Cherubini, 2007, Low plasma n-3 fatty acids and dementia in older persons: The InCHIANTI study, J. Gerontol. Ser. A Biol. Sci. Med. Sci., 62, 1120, 10.1093/gerona/62.10.1120

Milte, 2011, Erythrocyte polyunsaturated fatty acid status, memory, cognition and mood in older adults with mild cognitive impairment and healthy controls, Prostaglandins Leukot. Essent. Fat. Acids, 84, 153, 10.1016/j.plefa.2011.02.002

Yin, 2015, Nutrient biomarkers and vascular risk factors in subtypes of mild cognitive impairment: A cross-sectional study, J. Nutr. Health Aging, 19, 39, 10.1007/s12603-014-0510-8

Terano, 1999, Docosahexaenoic acid supplementation improves the moderately severe dementia from thrombotic cerebrovascular diseases, Lipids, 34, S345, 10.1007/BF02562338

Kotani, 2006, Dietary supplementation of arachidonic and docosahexaenoic acids improves cognitive dysfunction, Neurosci. Res., 56, 159, 10.1016/j.neures.2006.06.010

Chiu, 2008, The effects of omega-3 fatty acids monotherapy in Alzheimer’s disease and mild cognitive impairment: A preliminary randomized double-blind placebo-controlled study, Prog. Neuro Psychopharmacol. Biol. Psychiatry, 32, 1538, 10.1016/j.pnpbp.2008.05.015

Sinn, 2012, Effects of n-3 fatty acids, EPA v. DHA, on depressive symptoms, quality of life, memory and executive function in older adults with mild cognitive impairment: A 6-month randomised controlled trial, Br. J. Nutr., 107, 1682, 10.1017/S0007114511004788

Cazzola, 2012, Effects of DHA -phospholipids, melatonin and tryptophan supplementation on erythrocyte membrane physico-chemical properties in elderly patients suffering from mild cognitive impairment, Exp. Gerontol., 47, 974, 10.1016/j.exger.2012.09.004

Mahmoudi, M., Hedayat, M., Sharifi, F., Mirarefin, M., Nazari, N., Mehrdad, N., Ghaderpanahi, M., Tajalizadekhoob, Y., Badamchizade, Z., and Larijani, B. (2014). Effect of low dose ω-3 poly unsaturated fatty acids on cognitive status among older people: A double-blind randomized placebo-controlled study. J. Diabetes Metab. Disord., 13.

Ward, 2012, Prevalence of apolipoprotein E4 genotype and homozygotes (APOE e4/4) among patients diagnosed with Alzheimer’s disease: A systematic review and meta-analysis, Neuroepidemiology, 38, 1, 10.1159/000334607

Alzheimer's Association (2014). 2014 Alzheimer’s disease facts and figures. Alzheimer’s Dement., 10, e47–e92.

World Health Organization (2012). Dementia, WHO.

Kelley, 2015, The burden of health care costs for patients with dementia in the last 5 years of life, Ann. Intern. Med., 163, 729, 10.7326/M15-0381

Cummings, 2014, Repackaging FDA-approved drugs for degenerative diseases: Promises and challenges, Expert Rev. Clin. Pharmacol., 7, 161, 10.1586/17512433.2014.884923

Hebert, 2013, Alzheimer disease in the United States (2010–2050) estimated using the 2010 census, Neurology, 80, 1778, 10.1212/WNL.0b013e31828726f5

Astarita, G., Jung, K.M., Berchtold, N.C., Nguyen, V.Q., Gillen, D.L., Head, E., Cotman, C.W., and Piomelli, D. (2010). Deficient liver biosynthesis of docosahexaenoic acid correlates with cognitive impairment in Alzheimer’s disease. PLoS ONE, 5.

Igarashi, 2011, Disturbed choline plasmalogen and phospholipid fatty acid concentrations in Alzheimer’s disease prefrontal cortex, J. Alzheimer’s Dis., 24, 507, 10.3233/JAD-2011-101608

Quinn, 2010, Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: A randomized trial, JAMA, 304, 1903, 10.1001/jama.2010.1510

Prasad, 1998, Regional membrane phospholipid alterations in Alzheimer’s disease, Neurochem. Res., 23, 81, 10.1023/A:1022457605436

Soderberg, 1991, Fatty acid composition of brain phospholipids in aging and in Alzheimer’s disease, Lipids, 26, 421, 10.1007/BF02536067

Morris, 2003, Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease, Arch. Neurol., 60, 940, 10.1001/archneur.60.7.940

Shatenstein, 2007, Poor nutrient intakes during 1-year follow-up with community-dwelling older adults with early-stage Alzheimer dementia compared to cognitively intact matched controls, J. Am. Diet. Assoc., 107, 2091, 10.1016/j.jada.2007.09.008

Daiello, 2015, Association of fish oil supplement use with preservation of brain volume and cognitive function, Alzheimer’s Dement., 11, 226, 10.1016/j.jalz.2014.02.005

Conquer, 2000, Fatty acid analysis of blood plasma of patients with Alzheimer’s disease, other types of dementia, and cognitive impairment, Lipids, 35, 1305, 10.1007/s11745-000-0646-3

Tully, 2003, Low serum cholesteryl ester-docosahexaenoic acid levels in Alzheimer’s disease: A case–control study, Br. J. Nutr., 89, 483, 10.1079/BJN2002804

Wang, 2008, Nutritional biomarkers in Alzheimer’s disease: The association between carotenoids, n-3 fatty acids, and dementia severity, J. Alzheimer’s Dis., 13, 31, 10.3233/JAD-2008-13103

Lopez, 2011, High dietary and plasma levels of the omega-3 fatty acid docosahexaenoic acid are associated with decreased dementia risk: The rancho bernardo study, J. Nutr. Health Aging, 15, 25, 10.1007/s12603-011-0009-5

Phillips, 2012, Lower omega-3 fatty acid intake and status are associated with poorer cognitive function in older age: A comparison of individuals with and without cognitive impairment and Alzheimer’s disease, Nutr. Neurosci., 15, 271, 10.1179/1476830512Y.0000000026

Basun, 2008, Omega-3 supplementation in mild to moderate Alzheimer’s disease: Effects on neuropsychiatric symptoms, Int. J. Geriatr. Psychiatry, 23, 161, 10.1002/gps.1857

Cederholm, 2006, Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: Omegad study: A randomized double-blind trial, Arch. Neurol., 63, 1402, 10.1001/archneur.63.10.1402

Eriksdotter, 2015, Plasma fatty acid profiles in relation to cognition and gender in Alzheimer’s disease patients during oral omega-3 fatty acid supplementation: The omegad study, J. Alzheimer’s Dis., 48, 805, 10.3233/JAD-150102

Levi, 2014, Transfer of omega-3 fatty acids across the blood-brain barrier after dietary supplementation with a docosahexaenoic acid-rich omega-3 fatty acid preparation in patients with Alzheimer’s disease: The omegad study, J. Intern. Med., 275, 428, 10.1111/joim.12166

Connor, 1996, Relationship of iron to oligodendrocytes and myelination, Glia, 17, 83, 10.1002/(SICI)1098-1136(199606)17:2<83::AID-GLIA1>3.0.CO;2-7

Peters, 1996, Age-related changes in oligodendrocytes in monkey cerebral cortex, J. Comp. Neurol., 371, 153, 10.1002/(SICI)1096-9861(19960715)371:1<153::AID-CNE9>3.0.CO;2-2

Thompson, 2003, Dynamics of gray matter loss in Alzheimer’s disease, J. Neurosci., 23, 994, 10.1523/JNEUROSCI.23-03-00994.2003

Braak, 1996, Development of Alzheimer-related neurofibrillary changes in the neocortex inversely recapitulates cortical myelogenesis, Acta Neuropathol., 92, 197, 10.1007/s004010050508

Bartzokis, 2011, Alzheimer’s disease as homeostatic responses to age-related myelin breakdown, Neurobiol. Aging, 32, 1341, 10.1016/j.neurobiolaging.2009.08.007

Beal, 2005, Oxidative damage as an early marker of Alzheimer’s disease and mild cognitive impairment, Neurobiol. Aging, 26, 585, 10.1016/j.neurobiolaging.2004.09.022

Virtanen, J.K., Siscovick, D.S., Lemaitre, R.N., Longstreth, W.T., Spiegelman, D., Rimm, E.B., King, I.B., and Mozaffarian, D. (2013). Circulating omega-3 polyunsaturated fatty acids and subclinical brain abnormalities on MRI in older adults: The Cardiovascular Health Study. J. Am. Heart Assoc., 2.

Vermeer, 2003, Silent brain infarcts and the risk of dementia and cognitive decline, N. Engl. J. Med., 348, 1215, 10.1056/NEJMoa022066

Peters, 2004, The selfish brain: Competition for energy resources, Neurosci. Biobehav. Rev., 28, 143, 10.1016/j.neubiorev.2004.03.002

Whitmer, 2005, Midlife cardiovascular risk factors and risk of dementia in late life, Neurology, 64, 277, 10.1212/01.WNL.0000149519.47454.F2

Kalaria, 1999, Overlap between pathology of Alzheimer disease and vascular dementia, Alzheimer Dis. Assoc. Disord., 13, S115, 10.1097/00002093-199912003-00017

Roher, 2012, Cerebral blood flow in Alzheimer’s disease, Vasc. Health Risk Manag., 8, 599, 10.2147/VHRM.S34874

Jackson, 2012, DHA -rich oil modulates the cerebral haemodynamic response to cognitive tasks in healthy young adults: A near ir spectroscopy pilot study, Br. J. Nutr., 107, 1093, 10.1017/S0007114511004041

Beydoun, 2007, Plasma n-3 fatty acids and the risk of cognitive decline in older adults: The atherosclerosis risk in communities study, Am. J. Clin. Nutr., 85, 1103, 10.1093/ajcn/85.4.1103

Huang, T., Hu, X., Khan, N., Yang, J., and Li, D. (2013). Effect of polyunsaturated fatty acids on homocysteine metabolism through regulating the gene expressions involved in methionine metabolism. Sci. World J., 2013.

Ford, 2012, Plasma homocysteine and MTHFRC677T polymorphism as risk factors for incident dementia, J. Neurol. Neurosurg. Psychiatry, 83, 70, 10.1136/jnnp.2011.242446

Boneva, 2012, New insights into “GPR40-CREB interaction in adult neurogenesis” specific for primates, Hippocampus, 22, 896, 10.1002/hipo.20951

Brand, 2008, Docosahexaenoic acid-dependent iron accumulation in oligodendroglia cells protects from hydrogen peroxide-induced damage, J. Neurochem., 105, 1325, 10.1111/j.1471-4159.2008.05234.x

Gururajan, 2014, Is the mtor-signalling cascade disrupted in schizophrenia?, J. Neurochem., 129, 377, 10.1111/jnc.12622

Calon, 2005, Dietary n-3 polyunsaturated fatty acid depletion activates caspases and decreases NMDA receptors in the brain of a transgenic mouse model of Alzheimer’s disease, Eur. J. Neurosci., 22, 617, 10.1111/j.1460-9568.2005.04253.x

Nishikawa, 1994, Facilitatory effect of docosahexaenoic acid on N-methyl-d-aspartate response in pyramidal neurones of rat cerebral cortex, J. Physiol., 475, 83, 10.1113/jphysiol.1994.sp020051

Calon, 2004, Docosahexaenoic acid protects from dendritic pathology in an Alzheimer’s disease mouse model, Neuron, 43, 633, 10.1016/j.neuron.2004.08.013

Dyall, 2010, Omega-3 fatty acids reverse age-related decreases in nuclear receptors and increase neurogenesis in old rats, J. Neurosci. Res., 88, 2091, 10.1002/jnr.22390

Maarouf, C.L., Daugs, I.D., Kokjohn, T.A., Walker, D.G., Hunter, J.M., Kruchowsky, J.C., Woltjer, R., Kaye, J., Castano, E.M., and Sabbagh, M.N. (2011). Alzheimer’s disease and non-demented high pathology control nonagenarians: Comparing and contrasting the biochemistry of cognitively successful aging. PLoS ONE, 6.

Morimoto, 2011, Expression profiles of cytokines in the brains of Alzheimer’s disease (ad) patients compared to the brains of non-demented patients with and without increasing ad pathology, J. Alzheimer’s Dis., 25, 59, 10.3233/JAD-2011-101815

Parachikova, 2007, Inflammatory changes parallel the early stages of Alzheimer disease, Neurobiol. Aging, 28, 1821, 10.1016/j.neurobiolaging.2006.08.014

Cagnin, 2001, In-vivo measurement of activated microglia in dementia, Lancet, 358, 461, 10.1016/S0140-6736(01)05625-2

Edison, 2008, Microglia, amyloid, and cognition in Alzheimer’s disease: An [11C](R)PK11195-PET and [11C]PIB-PET study, Neurobiol. Dis., 32, 412, 10.1016/j.nbd.2008.08.001

Yokokura, 2011, In vivo changes in microglial activation and amyloid deposits in brain regions with hypometabolism in Alzheimer’s disease, Eur. J. Nucl. Med. Mol. Imaging, 38, 343, 10.1007/s00259-010-1612-0

Muller, 1995, Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer’s and de novo parkinson’s disease patients, Neurosci. Lett., 202, 17, 10.1016/0304-3940(95)12192-7

Heneka, 2014, Innate immune activation in neurodegenerative disease, Nat. Rev. Immunol., 14, 463, 10.1038/nri3705

Jia, 2005, Cerebrospinal fluid tau, abeta1–42 and inflammatory cytokines in patients with Alzheimer’s disease and vascular dementia, Neurosci. Lett., 383, 12, 10.1016/j.neulet.2005.03.051

Halle, 2008, The NALP3 inflammasome is involved in the innate immune response to amyloid-beta, Nat. Immunol., 9, 857, 10.1038/ni.1636

Salminen, 2008, Amyloid-beta oligomers set fire to inflammasomes and induce Alzheimer’s pathology, J. Cell. Mol. Med., 12, 2255, 10.1111/j.1582-4934.2008.00496.x

Hjorth, 2013, Omega-3 fatty acids enhance phagocytosis of Alzheimer’s disease-related amyloid-β42 by human microglia and decrease inflammatory markers, J. Alzheimer’s Dis., 35, 697, 10.3233/JAD-130131

Krstic, 2012, Deciphering the mechanism underlying late-onset Alzheimer disease, Nat. Rev. Neurol., 9, 25, 10.1038/nrneurol.2012.236

Weiser, M.J., Mucha, B., Denheyer, H., Atkinson, D., Schanz, N., Vassiliou, E., and Benno, R.H. (2015). Dietary docosahexaenoic acid alleviates autistic-like behaviors resulting from maternal immune activation in mice. Prostaglandins Leukot. Essent. Fat. Acids.

Wang, 2015, Effects of n-3 FA supplementation on the release of proresolving lipid mediators by blood mononuclear cells: The OmegAD study, J. Lipid Res., 56, 674, 10.1194/jlr.P055418

Serhan, 2015, Protectins and maresins: New pro-resolving families of mediators in acute inflammation and resolution bioactive metabolome, Biochim. Biophys. Acta, 1851, 397, 10.1016/j.bbalip.2014.08.006

Alfano, 2012, Fatigue, inflammation, and omega-3 and omega-6 fatty acid intake among breast cancer survivors, J. Clin. Oncol., 30, 1280, 10.1200/JCO.2011.36.4109

Belury, 2011, Omega-3 supplementation lowers inflammation and anxiety in medical students: A randomized controlled trial, Brain Behav. Immun., 25, 1725, 10.1016/j.bbi.2011.07.229

Bouwens, 2010, Postprandial dietary lipid-specific effects on human peripheral blood mononuclear cell gene expression profiles, Am. J. Clin. Nutr., 91, 208, 10.3945/ajcn.2009.28586

Vedin, 2008, Effects of docosahexaenoic acid-rich n-3 fatty acid supplementation on cytokine release from blood mononuclear leukocytes: The OmegAD study, Am. Soc. Nutr., 87, 1616

Green, 2007, Dietary docosahexaenoic acid and docosapentaenoic acid ameliorate amyloid-beta and tau pathology via a mechanism involving presenilin 1 levels, J.Neurosci., 27, 4385, 10.1523/JNEUROSCI.0055-07.2007

Ma, 2009, Beta-amyloid oligomers induce phosphorylation of tau and inactivation of insulin receptor substrate via c-Jun N-terminal kinase signaling: Suppression by omega-3 fatty acids and curcumin, J. Neurosci., 29, 9078, 10.1523/JNEUROSCI.1071-09.2009

Calon, 2011, Omega-3 polyunsaturated fatty acids in Alzheimer’s disease: Key questions and partial answers, Curr. Alzheimer Res., 8, 470, 10.2174/156720511796391881

Janssen, 2014, Long-chain polyunsaturated fatty acids (LCPUFA) from genesis to senescence: The influence of LCPUFA on neural development, aging, and neurodegeneration, Prog. Lipid Res., 53, 1, 10.1016/j.plipres.2013.10.002

Krstic, 2013, Decisive role of reelin signaling during early stages of Alzheimer’s disease, Neuroscience, 246, 108, 10.1016/j.neuroscience.2013.04.042

Yavin, 2009, Delayed cell migration in the developing rat brain following maternal omega 3 alpha linolenic acid dietary deficiency, Neuroscience, 162, 1011, 10.1016/j.neuroscience.2009.05.012

Burgaya, 2006, Reelin expression and glycosylation patterns are altered in Alzheimer’s disease, Proc. Natl. Acad. Sci. USA, 103, 5573, 10.1073/pnas.0601279103

Medhi, 2013, Insulin resistance: An emerging link in Alzheimer’s disease, Neurol. Sci., 34, 1719, 10.1007/s10072-013-1454-1

Tong, 2014, Brain metabolic dysfunction at the core of Alzheimer’s disease, Biochem. Pharmacol., 88, 548, 10.1016/j.bcp.2013.12.012

Velayudhan, 2010, Risk of developing dementia in people with diabetes and mild cognitive impairment, Br. J. Psychiatry, 196, 36, 10.1192/bjp.bp.109.067942

Hennebelle, 2015, Challenges to determining whether DHA can protect against age-related cognitive decline, Clin. Lipidol., 10, 91, 10.2217/clp.14.61

Pifferi, 2007, n-3 fatty acids modulate brain glucose transport in endothelial cells of the blood-brain barrier, Prostaglandins Leukot. Essent. Fat. Acids, 77, 279, 10.1016/j.plefa.2007.10.011

Pifferi, 2010, n-3 long-chain fatty acids and regulation of glucose transport in two models of rat brain endothelial cells, Neurochem. Int., 56, 703, 10.1016/j.neuint.2010.02.006

Pifferi, 2005, (n-3) polyunsaturated fatty acid deficiency reduces the expression of both isoforms of the brain glucose transporter glut1 in rats, J. Nutr., 135, 2241, 10.1093/jn/135.9.2241

Grimm, 2011, Docosahexaenoic acid reduces amyloid beta production via multiple pleiotropic mechanisms, J. Biol. Chem., 286, 14028, 10.1074/jbc.M110.182329

Fabelo, 2010, Lipid alterations in lipid rafts from Alzheimer’s disease human brain cortex, J. Alzheimer’s Dis., 19, 489, 10.3233/JAD-2010-1242

Fabelo, 2014, Altered lipid composition in cortical lipid rafts occurs at early stages of sporadic Alzheimer’s disease and facilitates APP/BACE1 interactions, Neurobiol. Aging, 35, 1801, 10.1016/j.neurobiolaging.2014.02.005

Hashimoto, 2015, The binding of aβ1–42 to lipid rafts of rbc is enhanced by dietary docosahexaenoic acid in rats: Implicates to Alzheimer’s disease, Biochim. Biophys. Acta, 1848, 1402, 10.1016/j.bbamem.2015.03.008

Gu, 2012, Nutrient intake and plasma beta-amyloid, Neurology, 78, 1832, 10.1212/WNL.0b013e318258f7c2

Flock, M.R., Skulas-Ray, A.C., Harris, W.S., Etherton, T.D., Fleming, J.A., and Kris-Etherton, P.M. (2013). Determinants of erythrocyte omega-3 fatty acid content in response to fish oil supplementation: A dose-response randomized controlled trial. J. Am. Heart Assoc., 2.

Cunnane, 2012, Plasma and brain fatty acid profiles in mild cognitive impairment and Alzheimer’s disease, J. Alzheimer’s Dis., 29, 691, 10.3233/JAD-2012-110629

Fortier, 2013, Disturbance in uniformly 13c-labelled DHA metabolism in elderly human subjects carrying the apoE ε4 allele, Br. J. Nutr., 110, 1751, 10.1017/S0007114513001268

Wu, 2015, Curcumin boosts DHA in the brain: Implications for the prevention of anxiety disorders, Biochim. Biophys. Acta, 1852, 951, 10.1016/j.bbadis.2014.12.005

Scheltens, 2012, Efficacy of souvenaid in mild Alzheimer’s disease: Results from a randomized, controlled trial, J. Alzheimer’s Dis., 31, 225, 10.3233/JAD-2012-121189

Serhan, 2002, Lipoxins and aspirin-triggered 15-epi-lipoxin biosynthesis: An update and role in anti-inflammation and pro-resolution, Prostaglandins Other Lipid Mediat., 68–69, 433, 10.1016/S0090-6980(02)00047-3

Serhan, 2004, Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their aspirin-triggered endogenous epimers: An overview of their protective roles in catabasis, Prostaglandins Other Lipid Mediat., 73, 155, 10.1016/j.prostaglandins.2004.03.005

Ariel, 2007, Resolvins and protectins in the termination program of acute inflammation, Trends Immunol., 28, 176, 10.1016/j.it.2007.02.007

Dalli, 2013, Resolvin D3 and aspirin-triggered resolvin D3 are potent immunoresolvents, Chem. Biol., 20, 188, 10.1016/j.chembiol.2012.11.010

Esiri, 2007, The interplay between inflammation and neurodegeneration in CNS disease, J. Neuroimmunol., 184, 4, 10.1016/j.jneuroim.2006.11.013

Etminan, M., Gill, S., and Samii, A. (2003). Effect of non-steroidal anti-inflammatory drugs on risk of Alzheimer’s disease: Systematic review and meta-analysis of observational studies. BMJ, 327.

Lehrer, 2014, Nasal nsaids for Alzheimer’s disease, Am. J. Alzheimers Dis. Other Dement., 29, 401, 10.1177/1533317513518658

Lewis, 2011, Neuroprotection for the warrior: Dietary supplementation with omega-3 fatty acids, Mil. Med., 176, 1120, 10.7205/MILMED-D-10-00466